Coverage and compliance of human papillomavirus vaccines in Paris: Demonstration of low compliance with non-school-based approaches

Journal of Adolescent Health

Volumn 47, Issue 3, 2010, Pages 237-241

  Rouzier, Roman ^a,b   Giordanella, Jean Pierre ^c  

^a HÔPITAL TENON   (France)

^b INSERM   (France)

^c Caisse Primaire d'Assurance Maladie de Paris   (France)

Author keywords

Compliance; Coverage; Human papilloma virus vaccine

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; FEMALE; FRANCE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REIMBURSEMENT; SCHOOL HEALTH EDUCATION; SOCIAL SECURITY; VACCINATION;

EID: 77955908360     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2010.04.006     Document Type: Article

References (17)

1. D.M. Harper Prevention of human papillomavirus infections and associated diseases by vaccination: A new hope for global public health Public Health Genomics 12 2009 319 330
2. A. Koulova, J. Tsui, and K. Irwin Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008 Vaccine 26 2008 6529 6541
3. D. Lévy-Bruhl, V. Bousquet, L.A. King country specific VENICE gate keepers and contact points The current state of introduction of HPV vaccination into national immunisation schedules in Europe: Results of the VENICE 2008 survey Eur J Cancer 45 2009 2709 2713
4. C. Bergeron, N. Largeron, and R. McAllister Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France Int J Technol Assess Health Care 24 2008 10 19
5. Vaccination schedule and recommendations from the "Haut conseil de la santé publique" in France Bull Epidémiol Hebdomadaire 16-17 2009 145 176
6. Breakthrough Vaccine Victim of Bad Publicity. Canadian National Post, February 19, 2008. Available at: www.nationalpost.com/news/canada/Story.html?id= 317535.
7. L. Brabin, S.A. Roberts, and R. Stretch Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: Prospective cohort study BMJ 336 2008 1056 1058
8. J.M. Brotherton, S.L. Deeks, and S. Campbell-Lloyd Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia Commun Dis Intell 32 2008 457 461
9. Centers for Disease Control and Prevention (CDC) Vaccination coverage among adolescents aged 13-17 years - United States, 2007 Morb Mortal Wkly Rep 57 2008 1100 1103
10. FUTURE II Study Group Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions N Engl J Med 356 2007 1915 1927
11. J. Paavonen, P. Naud, J. Salmerón HPV PATRICIA Study Group Greenacre M. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomized study in young women Lancet 374 2009 301 314
12. M. Stephan, C. Melinand, and A. Darras Compliance with HPV Vaccination in Girls and Young Women in France: First Results 2008 Eurogin Paris, France P VC-3. Available at http://www.eurogin.com/2008/EUROGIN2008-LastMinuteAbstracts. pdf
13. M. Stephan, C. Melinand, and A. Darras Compliance with HPV Vaccination in Girls and Young Women in Germany: First Results 2008 Eurogin Paris, France P VC-2. Available at http://www.eurogin.com/2008/EUROGIN2008-LastMinuteAbstracts. pdf
14. M. Watson, D. Shaw, and L. Molchanoff Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia Aust N Z J Public Health 33 2009 365 370
15. P. Deutsch, and N. Joannard Programme Régional d'Ile de France - Maladies Prévention Vaccinale 2009 Colloque Vaccination en Ile-de-France, 28 avril Paris, France
16. Kim JJ, Brisson M, Edmunds WJ, et al. Modeling cervical cancer prevention in developed countries. Vaccine 26 (Suppl 10):K76-86.
17. J.T. Schiller, X. Castellsagué, and L.L. Villa An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results Vaccine 26 Suppl 10 2008 K53 K61